AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 294: G401-G410, 2008. First published December 6, 2007; doi:10.1152/ajpgi.00454.2007
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/G401    most recent
00454.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kolachala, V. L.
Right arrow Articles by Sitaraman, S. V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolachala, V. L.
Right arrow Articles by Sitaraman, S. V.

INVITED REVIEWS

Purinergic receptors in gastrointestinal inflammation

Vasantha L. Kolachala, Rahul Bajaj, Meghana Chalasani, and Shanthi V. Sitaraman

Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia

Submitted 3 October 2007 ; accepted in final form 2 December 2007

Purinergic receptors comprise a family of transmembrane receptors that are activated by extracellular nucleosides and nucleotides. The two major classes of purinergic receptors, P1 and P2, are expressed widely in the gastrointestinal tract as well as immune cells. The purinergic receptors serve a variety of functions from acting as neurotransmitters, to autocoid and paracrine signaling, to cell activation and immune response. Nucleosides and nucleotide agonist of purinergic receptors are released by many cell types in response to specific physiological signals, and their levels are increased during inflammation. In the past decade, the advent of genetic knockout mice and the development of highly potent and selective agonists and antagonists for the purinergic receptors have significantly advanced the understanding of purinergic receptor signaling in health and inflammation. In fact, agonist/antagonists of purinergic receptors are emerging as therapeutic modalities to treat intestinal inflammation. In this article, the distribution of the purinergic receptors in the gastrointestinal tract and their physiological and pathophysiological role in intestinal inflammation will be reviewed.

adenosine receptor; P2 receptor; inflammation


Address for reprint requests and other correspondence: S. V. Sitaraman, Division of Digestive Diseases, Rm. 201-F, 615, Michael St., Whitehead Research Bldg., Emory Univ., Atlanta, GA 30322 (e-mail: ssitar2{at}emory.edu)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.